搜尋結果
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 5 小時前The FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed ...
Barclays upgrades a little-known biotech stock that it says can more than double
CNBC· 1 小時前This drug discovery stock can benefit from expansion of its breast cancer treatment.
Council Post: The Growing Cybersecurity Disconnect Leaves Enterprises Exposed
Forbes· 11 小時前IRONSCALES founder & CEO Eyal Benishti is a pioneering security software engineer & executive ...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 5 小時前Have a confidential tip for our reporters? US regulators’ decision on whether to approve ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 5 小時前, opens new tab respiratory syncytial virus (RSV) vaccine due to some "administrative ...
Billionaire-Backed Cancer Researcher Claire Mazumdar Finds Entrepreneurial Niche
Forbes· 11 小時前As the niece of biotech billionaire Kiran Mazumdar-Shaw—the founder of listed biopharma firm ...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 4 日前This article is part of an ongoing series on novel cancer advances, including immunotherapies ...
Sustainability professionals turning to AI for help with materiality assessments, Reuters ...
Reuters· 8 小時前Sustainability reporting and data collection – more specifically, the ability to report ...
As Global Warming Soars, These XPRIZE Carbon Removal Finalists Are More Needed Than Ever
Forbes· 11 小時前The XPRIZE Carbon Removal competition unveils top 20 finalist teams in the $100M competition to ...
Exclusive: Huawei's new phone uses more China-made parts, memory chip
Reuters· 1 日前Huawei's latest high-end phone features more Chinese suppliers, including a new flash ...